KARYOPHARM THERAPEUTICS
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation. Karyopharm Therapeutics is developing small molecule drugs that will modulate the activity of critical pathways in cancer, inflammation, and cell proliferation (e.g. FOXO, NFкB, P53, pRB) by targeting the nuclear pore complex machinery, which controls the import and export of proteins between the nucleus and cytoplasm. To successfully control transport through the nuclear pore complex, the company will use its unique technology platform, developed by Sharon Shacham, to identify novel small molecules, optimize them into clinical candidates, and to evaluate them in subsequent human clinical studies.
KARYOPHARM THERAPEUTICS
Industry:
Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.karyopharm.com
Total Employee:
251+
Status:
Active
Contact:
+1 617 658 0600
Email Addresses:
[email protected]
Total Funding:
381.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Mobile Non Scaleable Content
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Karyopharm Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Karyopharm Therapeutics
Delphi Ventures
Delphi Ventures investment in Series B - Karyopharm Therapeutics
Delphi Ventures
Delphi Ventures investment in Series B - Karyopharm Therapeutics
Chione
Chione investment in Series A - Karyopharm Therapeutics
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation investment in Grant - Karyopharm Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-10 | Karyopharm Promotes Sohanya Cheng to Chief Commercial Officer |
Official Site Inspections
http://www.karyopharm.com Semrush global rank: 2.07 M Semrush visits lastest month: 10.09 K
- Host name: 156.218.184.35.bc.googleusercontent.com
- IP address: 35.184.218.156
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
